OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Editorial Board	140
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”	118
Topical liquid formulation of bacteriophages for metered-dose spray delivery	88
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio	86
Rationalisation of the purification process for a phage active pharmaceutical ingredient	79
Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer	77
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles	77
Editorial Board	76
Editorial Board	72
Editorial Board	72
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions	70
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes	70
Key factors governing the reconstitution time of high concentration lyophilized protein formulations	69
Homogeneity and mechanical properties of orodispersible films loaded with pellets	64
Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer’s d	61
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery	60
COSMO models for the pharmaceutical development of parenteral drug formulations	57
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment	57
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps	56
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody	55
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study	54
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations	52
Question-based review for pharmaceutical development: An enhanced quality approach	52
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans	51
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells	51

Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response	50
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]	49
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration	47
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study	47
Palmitic acid-modified human serum albumin paclitaxel nanoparticles targeting tumor and macrophages against breast cancer	45
A review of paediatric injectable drug delivery to inform the study of product acceptability – An introduction	41
Co-axial electrosprayed RAD001-loaded polycaprolactone/polyvinyl alcohol core–shell particles for treating pediatric brain tumours	40
Enhancing therapeutic efficacy: In vivo mechanisms and biochemical effects of lycopene encapsulated in nanomicelles for acute inflammation and lipid metabolism	40
In silico evaluation of corneal patch eluting anti-VEGF agents concept	38
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development	37
Berberine-loaded mannosylerythritol lipid-B nanomicelles as drug delivery carriers for the treatment of Helicobacter pylori biofilms in vivo	36
Boosting the therapeutic efficacy of discoidal nanoconstructs against glioblastoma with rationally designed PEG-Docetaxel conjugates	36
Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction	36